Humana Inc. (NYSE:HUM) Receives Average Recommendation of “Hold” from Analysts

Shares of Humana Inc. (NYSE:HUM) have earned a consensus rating of “Hold” from the twenty-eight ratings firms that are presently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a sell rating, sixteen have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $291.3478.

HUM has been the subject of a number of recent analyst reports. Bank of America upped their price target on shares of Humana from $267.00 to $340.00 and gave the stock a “neutral” rating in a report on Thursday, June 4th. Guggenheim lifted their price objective on shares of Humana from $252.00 to $269.00 and gave the company a “buy” rating in a research note on Thursday, April 30th. Robert W. Baird cut their target price on Humana from $264.00 to $205.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Deutsche Bank Aktiengesellschaft downgraded Humana from a “buy” rating to a “hold” rating in a report on Wednesday, May 20th. Finally, UBS Group reiterated a “neutral” rating on shares of Humana in a research note on Monday.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Montag A & Associates Inc. increased its position in Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 94 shares in the last quarter. CoreCap Advisors LLC boosted its position in Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after buying an additional 37 shares in the last quarter. Fideuram Asset Management Ireland dac bought a new stake in shares of Humana during the fourth quarter worth $27,000. Reflection Asset Management bought a new stake in shares of Humana during the fourth quarter worth $29,000. Finally, Rosenberg Matthew Hamilton increased its holdings in shares of Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after buying an additional 68 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Stock Down 0.3%

Shares of NYSE HUM opened at $360.84 on Friday. The stock has a market capitalization of $43.32 billion, a P/E ratio of 38.59, a PEG ratio of 2.06 and a beta of 0.76. The stock’s fifty day moving average is $282.64 and its 200 day moving average is $240.76. Humana has a 52 week low of $163.11 and a 52 week high of $380.86. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, topping the consensus estimate of $9.97 by $0.34. The business had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. Humana’s revenue was up 23.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Sell-side analysts forecast that Humana will post 9.04 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Friday, June 26th. Humana’s payout ratio is currently 37.86%.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.